RGC - Company ID 0001829667
Regencell Bioscience Holdings Ltd trades as RGC and has a market capitalization of $3.01 B, making it the #1824 largest US-listed company by market value. This page tracks Regencell Bioscience Holdings Ltd through 82 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-22 |
| Prospectus supplement | 424B5 | 2026-05-19 |
| 6-K | - | 2026-05-19 |
| 6-K | - | 2026-05-19 |
| 6-K | - | 2026-05-08 |
| 6-K | - | 2026-04-17 |
| 6-K | - | 2026-03-30 |
| 6-K | - | 2026-03-30 |
The largest companies sharing Regencell Bioscience Holdings Ltd's SEC industry classification (medicinal chemicals & botanical products).
Regencell Bioscience Holdings Ltd (RGC) has a market capitalization of $3.01 B as of 2026-07-09, ranking #1824 among US-listed companies.
In its latest fiscal year Regencell Bioscience Holdings Ltd reported a net loss of $3.58M.